← Back to Search

Behavioral Weight Loss (BWL) for Obesity

Phase 2 & 3
Waitlist Available
Research Sponsored by Yale University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Have a BMI ≥30 (or BMI ≥27 with a medical comorbidity) and ≤50 kg/m2
Be an otherwise healthy subject without uncontrolled medical problems, as determined by the study physician and medical co-investigators (physical examination, laboratory studies).
Timeline
Screening 3 weeks
Treatment Varies
Follow Up post-treatment (3 months)
Awards & highlights

Study Summary

This trial will study two ways to help people who have regained weight after weight-loss surgery. One group will get a medicine, and the other will get help changing their behavior.

Eligible Conditions
  • Obesity

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
You are available for participation in the study for up to 3 months.
Select...
You are at least 18 years old and not 70 years old.
Select...
You have had laparoscopic Roux-en-Y gastric bypass or sleeve gastrectomy.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~post-treatment (3 months)
This trial's timeline: 3 weeks for screening, Varies for treatment, and post-treatment (3 months) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Body Mass Index
Secondary outcome measures
Depressive Symptoms
Eating Disorder Psychopathology
Food Craving

Trial Design

2Treatment groups
Experimental Treatment
Group I: Behavioral Weight Loss + MedicationExperimental Treatment2 Interventions
Group II: Behavioral Weight LossExperimental Treatment2 Interventions
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Behavioral Weight Loss (BWL)
2016
Completed Phase 3
~790
Early Responder: BWL continued
2021
Completed Phase 3
~30
Early Non-responder: BWL continued with medication added
2021
Completed Phase 3
~30

Find a Location

Who is running the clinical trial?

Yale UniversityLead Sponsor
1,846 Previous Clinical Trials
2,736,453 Total Patients Enrolled
60 Trials studying Obesity
248,148 Patients Enrolled for Obesity
American Psychological FoundationOTHER
18 Previous Clinical Trials
1,881 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~7 spots leftby Apr 2025